These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2456132)

  • 1. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) enhances tryptophan hydroxylase activity in mouse striatum, but not in the frontal cortex.
    Fukuda H; Hara K; Nakamura S; Kimura H; Kameyama M
    Brain Res; 1988 May; 449(1-2):399-402. PubMed ID: 2456132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible serotoninergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse striatum studied by neurochemical and immunohistochemical approaches.
    Hara K; Tohyama I; Kimura H; Fukuda H; Nakamura S; Kameyama M
    Brain Res; 1987 May; 410(2):371-4. PubMed ID: 3297254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat.
    Matsuda LA; Schmidt CJ; Hanson GR; Gibb JW
    Neuropharmacology; 1986 Mar; 25(3):249-55. PubMed ID: 2871513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
    Andrews AM; Murphy DL
    J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of MPTP on uridine uptake in murine nerve cells.
    Pakkenberg H; Pakkenberg B; Fog R; Eldrup E
    Brain Res; 1988 Sep; 460(1):146-9. PubMed ID: 2464401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.
    Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu I; Nagatsu T
    Neurosci Lett; 1987 Sep; 80(2):213-8. PubMed ID: 2891089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.
    Melamed E; Pikarski E; Goldberg A; Rosenthal J; Uzzan A; Conforti N
    Brain Res; 1986 Dec; 399(1):178-80. PubMed ID: 3492237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different toxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) on the nigrostriatal and mesolimbic pathways.
    Ambrosio S; Gerli P; Perego C; Algeri S
    Eur J Pharmacol; 1987 Jan; 133(2):239-41. PubMed ID: 2880741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum.
    Pileblad E; Fornstedt B; Clark D; Carlsson A
    J Pharm Pharmacol; 1985 Oct; 37(10):707-11. PubMed ID: 2416901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 1-methyl-4-(p-chlorophenyl)-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and p-chloroamphetamine as monoamine depletors.
    Fuller RW; Hemrick-Luecke SK; Robertson DW
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):57-65. PubMed ID: 2417293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart.
    Wallace RA; Boldry R; Schmittgen T; Miller D; Uretsky N
    Life Sci; 1984 Jul; 35(3):285-91. PubMed ID: 6146909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparations.
    Heikkila RE; Youngster SK; Manzino L; Cabbat FS; Duvoisin RC
    J Neurochem; 1985 Jan; 44(1):310-3. PubMed ID: 3871120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse.
    Hallman H; Lange J; Olson L; Strömberg I; Jonsson G
    J Neurochem; 1985 Jan; 44(1):117-27. PubMed ID: 3880581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia.
    Zeng BY; Iravani MM; Jackson MJ; Rose S; Parent A; Jenner P
    Neurobiol Dis; 2010 Dec; 40(3):599-607. PubMed ID: 20713157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and late effects of systemically administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on tyrosine hydroxylase activity in vitro and on tyrosine hydroxylation in tissue slices of mouse striatum.
    Hirata Y; Nagatsu T
    Neurosci Lett; 1986 Jul; 68(2):245-8. PubMed ID: 2875421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical aspects of Parkinson-dementia complex.
    Nakamura S; Fukuda H; Hara K; Fukuyama H; Kameyama M
    Eur Neurol; 1988; 28 Suppl 1():24-8. PubMed ID: 3259926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional serotonin metabolism in the brain of transgenic mice lacking monoamine oxidase A.
    Popova NK; Gilinsky MA; Amstislavskaya TG; Morosova EA; Seif I; De Maeyer E
    J Neurosci Res; 2001 Nov; 66(3):423-7. PubMed ID: 11746359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.